Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Minority Interest of $14000.0 in Q3 2015, down 74.55% quarter-over-quarter from $55000.0 in Q2 2015, and down 84.44% on a YoY basis from $90000.0 in Q3 2014.
Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015) Analysis & Trends
Jazz Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $14000.0 for Q3 2015.
- In Q3 2015, Minority Interest fell 84.44% year-over-year to $14000.0; the TTM figure through Sep 2015 stood at $14000.0 (down 84.44% YoY), while the FY2014 annual figure was $64000.0, changed N/A from the prior year.
- Minority Interest was $14000.0 for Q3 2015 at Jazz Pharmaceuticals, down from $55000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $17.6 million in Q1 2014 to a low of $14000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 14,000.00 |
| Jun 30, 2015 | 55,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 396,000.00 |
| Mar 31, 2014 | 17.62 Mn |